Achieving the therapeutic benefits of Niaspan® in daily practice
Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78282-7877, USA
Corresponding author. Tel: +1 210 358 7402; fax: +1 210 358 7406. E-mail address: charles.reasner{at}uhs-sa.com
Aims The purpose of this aricle is to discuss the use of niacin to reduce cardiovascular events in patients with diabetes.
Methods and Results Five common misconceptions regarding the use of niacin are discussed and practical suggestions to decrease flushing with niacin are outlined. Evidence that combining niacin with statin therapy is presented.
Conclusions That simultaneous lowering of LDL-cholesterol with statins and raising HDL-cholesterol with niacin is a rational and effective strategy for preventing cardiovascular disease in patients with diabetes.
Key Words: Type 2 diabetes Dyslipidaemia HDL-cholesterol Nicotinic acid Niacin